The expression of specific cancer-associated PCNA (caPCNA) isoforms, which are not uniformly present across all malignancies, creates an additional layer of differential susceptibility, as inhibitors like AOH1996 are designed to target these variant forms (Gu et al., 2023b). This evidence concerns the gene PCNA and cancer.